103 Pd seed is being used for prostate brachytherapy. Additionally, the dose enhancement effect of gold nanoparticles (GNP) has been reported in previous studies. The aim of this study was to characterize the dosimetric effect of gold nanoparticles in brachytherapy with a 103 Pd source. Two brachytherapy seeds including 103 Pd source was simulated using MCNPX Monte Carlo code. The seeds' models were validated by comparing the MC with reported results. Then, GNPs (10 nm in diameter) with a concentration of 7mg Au/g were simulated uniformly inside the prostate of a humanoid computational phantom. Additionally, the dose enhancement factor (DEF) of nanoparticles was calculated for both modeled brachytherapy seeds. A good agreement was found between the MC calculated and the reported dosimetric parameters. For both seeds, an average DEF of 23% was obtained in tumor volume for prostate brachytherapy. The application of GNPs in conjunction with 103 Pd seed in brachytherapy can enhance the delivered dose to the tumor and consequently leads to better treatment outcome.
Introduction
Brachytherapy plays a crucial role in the treatment of prostate cancer. Different radioactive sources are employed to deliver the prescribed dose properly to the prostate and lower the received dose to normal surrounding tissues. However, the studies on the optimization of the treatment method and enhancing the treatment outcome are still conducted. For example, Yang and Wang treated twenty patients with prostate cancer and used different sources including 131 Cs, 103 Pd, and 125 I seeds. Finally, they preferred 131 Cs because less seed needed [1] . Ververs J et al. conducted a comparative study in prostate brachytherapy with 103 Pd. They concluded that based on clinical scenarios, planning with the CivaString source significantly reduced the number of required needles while delivering similar dose distributions to the prostate, urethra, and rectum. Planning was dramatically simplified, and optimization was replaced by simple guidelines that allowed the creation of high-quality treatment plans within minutes [2] . Rivard et al. studied 103 Pd seeds usage to the prostate gland cancer and calculated in detail the dosimetric parameters of a model of 103 Pd seeds for prostate brachytherapy. They studied the new designed CivaString and CivaThin sources in comparison to the encapsulated 103 Pd sources. In their designed seeds, dose distributions of both source types had minimal anisotropy in comparison to conventional 103 Pd seeds [3] . 103 Pd seeds are the highly used radioactive sources applied in brachytherapy of prostate cancer. These sources emit low energy photons which make them preferred candidates for brachytherapy of prostate cancer. These sources provide a high dose region inside the tumor volume, while they deliver a very small amount of radiation dose to the critical peripheral organs such as bladder and rectum.
There are enormous studies on the dose enhancement effect of gold nanoparticles (GNP) in radiation therapy with radioactive sources [4] [5] [6] [7] . It indicates the strong interest of researchers worldwide to use the brachytherapy sources with nanoparticles inside a tumor to improve the treatment outcome [8] [9] [10] [11] [12] . In fact, radiation dose enhancement of GNPs stems from higher probability of interaction of radiation with the gold atoms. In other words, the probability of photoelectric interaction which is dependent on the atomic number of a material increases significantly for gold atoms. Thus, production of the photoelectrons which deposit their energy in short distances relative to gold atoms causes a higher dose delivery to the medium containing a sufficient amount of GNPs [13] [14] [15] [16] [17] [18] [19] . Also, in microscopic studies, it was shown a high dose gradient region with a few µm distance around the GNPs which results in enhanced absorbed dose in the target organ [18] [19] [20] . GNPs and other nanoparticles have been studied for their potential dose enhancement effect in brachytherapy [21] [22] [23] . In Monte Carlo (MC) studies, a newly fabricated 103 Pd source was investigated for its dosimetric property for application in brachytherapy of prostate cancer [24] [25] [26] [27] [28] . They confirmed its dosimetric suitability for brachytherapy of prostate cancer. However, the dose enhancement factor of GNPs with this new source of 103 Pd and the other clinically used seed of 125 I have not been studied. It is worth to estimate their dose enhancement effect in the treatment of GNP-loaded prostate tumor. The aim of this study was to characterize the dosimetric properties of two newly produced radioactive seeds including the IR01- 103 Pd source for application in prostate brachytherapy.
Also, the dose enhancement of these seeds in conjunction with GNPs was evaluated for prostate brachytherapy.
Materials and Methods
In the current study, the MCNPX MC (ver.2.7.0) code (Los Alamos National Laboratory) was employed for MC simulations. In Figure 1 , the simulated IR01-103 Pd seed was schematically shown. Four resin beads with a diameter of 0.06 cm containing the radioactive 103 Pd were used to construct the seed with a length of 0.45 cm length. Moreover, a cylindrical copper cell with 0.15 cm length was located at the center of the seed. The composition of resin beads (density of 1.14 g/cm 3 )
was made of Hydrogen (8%), Carbon (90%), Nitrogen (0.3%), Chlorine (0.7%) and Pd (1%). The radiation spectrum of 103 Pd and cross-section of TG43U1 publication were used for source definition in the MC model [29] . The 103 Pd seed had an average energy of 21 keV for photons, the half-life of 16.97 days. According to the updated AAPM Task group report No. 43, dosimetric characteristics of the both simulated seed as brachytherapy sources such as dose rate constant Ʌ (cGy h -1 U -1 ), geometry function, radial dose function and anisotropy function calculated were estimated using MC method [30] . For dose calculations around sources, a water phantom with a dimension of 10×10×10 cm 3 and a seed in its center were modeled (Figure 2) . In order to score dose deposition around the seed, the lattice card was used and the water phantom was divided into some voxels with a dimension of 2×2×2 mm 3 . The dose deposition was scored using tally *F8 which calculates the energy in terms of MeV per initial photon in each scoring cell. All dosimetric data were extracted from dose distribution data around the seed. For dose enhancement calculations, a seed was simulated in the center of the prostate gland of Korean man computational phantom. Additionally, a concentration of 7 mg Au/g GNPs (diameter = 10 nm) was uniformly simulated in the prostate gland tissue using lattice and universe card properties in MCNPX code. All the MC calculated doses were relative and for absolute dose calculations, a prescribed dose of 145 Gy was considered for the cancerous prostate. The initial dose rate of a 19.7 cGy·h -1 also was considered in the calculations. In addition to the dose calculation for prostate, the average received dose for bladder and rectum was also calculated and two cases of with and without GNP-loaded prostate were considered. A humanoid computational phantom named as Korean man or (KTMAN-2) was utilized to simulate the seed implementation inside the prostate gland and organs at risks (Figure 3) . This phantom contains 29 organs and 19 skeletal regions. It was produced from cross-sectional x-ray computed tomography images. It is made of 300×150×344 voxels with a spatial resolution of 2×2×5 cm 3 . The anatomic properties of an average Korean man with a height of 171 cm and a weight of 70 kg have been considered in the structure of this computational phantom. For dose enhancement calculations, the voxels of the prostate gland were filled with GNPs using Lattice card in MCNPX code. The dose calculations were performed for voxels of prostate gland including two cases of with and without GNPs. 
Results and Discussion
Dose rate constant, geometry and radial dose functions were calculated for the simulated seed. It was tabulated in Figure 4 . Calculated DEF in the first µm in the vicinity of a single GNP was 48% and dropped to 5% in 30 µm from the GNP. The average DEF in the presence of all GNPs was approximately 23%. This phenomenon showed a high dose gradient in the vicinity of the GNPs which can kill the cancer cell effectively in the site. In Table 1 , the calculated dosimetric parameters of the simulated source were described. In the case of dose rate constant, the difference between our results and TLD measurement for the same model source was 24%. This higher difference with measurement can be attributed to the measurement conditions such as the medium in which the results were obtained. Our calculation was performed in a humanoid phantom and the densities of bladder, prostate, and rectal wall were considered 1.023, 1.025, and 1.013 g/cm 3 respectively, while in the measurement study the perspex phantom with a density of 1.08 g/cm 3 was used. Our MC calculation in the humanoid phantom 0.666 ± 0.01 TLD dosimetry in Perspex [34] 0.83 ± 0.05 MC simulation in Liquid water [34] 0.69 ± 0.05
Geometric parameters were calculated different radii including r = 0.25 cm, 0.5 cm, and 5 cm. our results were in good agreement with the reported measured values of Raisali et al. [31] . Our simulations were performed at 15°, 30°, 45°, 60°, and 90° angles. The results were tabulated in Table 2 . It can be seen that a very small difference exists between our reported normalized geometry function and the other similar work [22, 25, 28, 30, 31] . Additionally, radial dose function was tabulated in Table 3 which includes TLD measured and MCderived values for the same source of 103 Pd. Furthermore, the anisotropy factor for the simulated brachytherapy seed was obtained and compared with reported values in Table 4 . Our results were compared with the MC study of Raisali et al. the [31] . There was a close agreement between our results and their reported values.
In the case of DEF of GNPs in the brachytherapy, some paper has been published [35, [37] [38] [39] [40] [41] [42] . The studies show that for low energy sources, DEF of nanoparticles is higher than high energy sources. It may be attributed to this fact that the photoelectric phenomenon is dominant in low energies and also photoelectrons produced from low energy photons deposit their energy in short range from the production site. Studying the dose distribution around a single GNP showed a dramatic DEF in a few µm distance from the GNP which creates a dose inhomogeneity inside target region as well as higher cell killing effect in the vicinity of GNPs.
Conclusion
We concluded that using the GNPs and low energy-high dose rate 103 Pd leads to significant DEF in brachytherapy of prostate cancer. Furthermore, a maximum dose enhancement of 48% plus dramatic dose gradient in micro-scale were found in the vicinity of GNPs which can cause higher cells kill effect in tumoral tissue compared to the conventional treatment without using GNPs. Our study showed 103 Pd with GNPs can be considered as an applicable choice for prostate brachytherapy. 
